OpenEvidence closed a $250 million funding round, doubling its valuation to $12 billion as its ad-supported AI tool gains traction with US physicians.

AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.

With a population of over 1.4 billion and a rising chronic disease burden, the demands on the system are expanding rapidly. Moving healthcare spending closer to 5% of GDP is essential to address ...

Microbot Medical targets $4M in 2026 revenue with the LIBERTY robotic system launch and a $1.9 price target after its capital raise. See why MBOT stock is a hold.

LifeQuotes.com, the life insurance price comparison service that offers instant quotes from 50 highly-rated life insurers announced today that its direct customer reviews surpassed 146,000 at 4.7 ...

OpenEvidence, an AI startup whose tools are used by U.S. physicians, has raised $250 million in fresh funding at a $12 ...

TL;DR: FUE pricing is usually driven by graft count and the clinic’s per-graft rate, then nudged up or down by who performs ...

The Randolph County Commission has approved a quote for the purchase of equipment for a new ambulance for the Randolph County Emergency Squad. President David Kesling told the Commission that a ...

"Guardian is a natural partner for PerfectQuote," said Curtis Kadohama, Chief Product ffice of PerfectQuote. "Their forward-thinking approach aligns perfectly with our mission to connect brokers and ...

The new feature can give tailored responses based on medical records and wellness app data, according to ChatGPT’s maker. But ...